We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A novel atheroprotective role of MF59-like adjuvant when co-administered with CETP vaccine in rabbit model of atherosclerosis.
- Authors
Aghebati, Tamara; Badiee, Ali; Mohammadpour, Amir Hooshang; Abnous, Khalil; Afshar, Mohammad; Jaafari, Mahmoud Reza; Nazemi, Saeed; Issazadeh, Sobhan; Hashemzadeh, Saeed; Zare, Mohammad
- Abstract
Objective(s): In this study, for the first time, MF59 adjuvant was used to develop a cholesteryl ester transfer protein (CETP) vaccine. The efficacy of the vaccine was compared with the efficacy of CETP vaccine formulated with Alum/CpG, the formulation that its immunogenicity has been already demonstrated in rabbit and mice. Materials and Methods: Tetanus toxoid- CETP peptide (TT-CETP) was mixed with Alum/CpG or MF59-like and administered subcutaneously for total five times in rabbit model of atherosclerosis. Anti-TT-CETP specific antibody, CETP activity in sera and mRNA level of cytokine IL-4 and IFN-γ in peripheral mononuclear cells were determined. Therapeutic response was also examined by tracking serum lipoprotein levels and pathologic observation of atherosclerotic lesions at aortic site. Results: More anti-TT-CETP antibody was found in Alum/CpG vaccinated rabbits compared to buffer (P<0.001). Antibody induced by MF59-like formulation was not significantly higher than buffer. CETP activity and lipoprotein levels were not significantly different between vaccinated and control rabbits. The mRNA level of IL-4 was significantly lower than buffer while, IFN-γ gene expression was significantly higher in both vaccinated groups. Atherosclerosis thickness grade of aorta was dramatically lower than buffer (P<0.01) in both vaccinated groups. Conclusion: It is concluded that MF59-adjuvanted CETP vaccine showed anti-atherosclerosis properties, but the protective effect could not be directly attributed to the immune response induced by anti TT-CETP antibody and CETP inhibition. Further studies are needed to explain the anti-atherosclerosis properties of MF59 in the presence of TT-CETP peptide.
- Subjects
CHOLESTERYL ester transfer protein; ANIMAL models of atherosclerosis; DRUG efficacy; TETANUS; CYTOKINES; MESSENGER RNA
- Publication
Iranian Journal of Basic Medical Sciences, 2016, Vol 19, Issue 12, p1345
- ISSN
2008-3866
- Publication type
Article
- DOI
10.22038/ijbms.2016.7922.